Curaxys SL - Company Review
Curaxys SL - Company ReviewSummary
Curaxys SL (Curaxys) is a biopharmaceutical company that conducts research and develops biosimilars. The company’s activities include research, development, production and commercialization of therapeutical proteins. It also produces generic products such as clopidogrel, anastrozol, gabapentin and venlafaxin, among others. Curaxys provides CRX02 trastuzumab, a humanised monoclonal antibody designed to activate the body’s immune system and suppress the HER2 protein. The company’s services include cell lines developed from cDNA; proof of concept; cell culture process development; assay tech transfer; working cell bank; assay functional, structural and activity; protein purification; engineering pilot run; cGMP manufacturing for phase I and II clinical trials; commercial production; regulatory-compliant GMP facilities; and others. Curaxys is headquartered in Cadiz, Spain.
This comprehensive company report of Curaxys SL provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.